2021
DOI: 10.1080/10408398.2021.1968787
|View full text |Cite
|
Sign up to set email alerts
|

Folic acid supplementation and blood pressure: a GRADE-assessed systematic review and dose-response meta-analysis of 41,633 participants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 62 publications
0
6
0
Order By: Relevance
“…Furthermore, the lower BP that was measured in the current study, compared with the results four years ago (115/55 mmHg vs. 128/62 mmHg), may be explained by lower sodium [ 68 , 69 ] and higher plant protein [ 70 ], PUFA [ 71 ], vitamin C [ 72 ], folic acid [ 73 ], and potassium intake [ 69 , 71 ]. In addition, it is known that physical activity has beneficial effects on blood pressure [ 74 ] and that the athlete was highly active four years ago; however, she currently reported even higher weekly exercise volume (20 h/w vs. 25 h/w in 2018 and 2022).…”
Section: Discussionmentioning
confidence: 74%
“…Furthermore, the lower BP that was measured in the current study, compared with the results four years ago (115/55 mmHg vs. 128/62 mmHg), may be explained by lower sodium [ 68 , 69 ] and higher plant protein [ 70 ], PUFA [ 71 ], vitamin C [ 72 ], folic acid [ 73 ], and potassium intake [ 69 , 71 ]. In addition, it is known that physical activity has beneficial effects on blood pressure [ 74 ] and that the athlete was highly active four years ago; however, she currently reported even higher weekly exercise volume (20 h/w vs. 25 h/w in 2018 and 2022).…”
Section: Discussionmentioning
confidence: 74%
“…The NutriGrade ratings for a dietary factor were often the same for SBP and DBP and the evidence was generally for populations of mixed health statuses, the exceptions were specified. We summarized the effects of diet exposure on blood pressure and risk of hypertension in Table 1 [ [11] , [13] , [15] , [17] , [18] , [19] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [62] , [66] , [67] , [71] , [72] , [73] , [74] , [75] , [76] , [77] , [79] , [80] , [81] , [82] , [85] , [86] , [87] , [88] , [89] , [90] , [91] , [92] , [93] , [94] , [95] , [96] , [97] , [98] , [99] , [100] , [101] , [102] , [103] , [104] , …”
Section: Resultsmentioning
confidence: 99%
“…Folic acid is commonly used as a prenatal supplement, which may reduce the risk associated with maternal MTHFR 677CT genotype polymorphisms. A recent study discovered that taking a high-dose folic acid supplement (5 mg/day) could lower SBP and DBP 60. On the other hand, McRae MP61 examined the effect of folic acid supplementation in patients with hypertension in a previous study.…”
Section: Discussionmentioning
confidence: 99%